1. Pink Sheet
  2. >>Geography
  3. >>Europe

EMA Awards Funding For Pan-African Drug Review Pilot

 
• By Ian Schofield

A regulatory initiative underway in Africa is testing out continental-level assessments of new drug applications that its sponsors say could provide the foundations for a “robust and well-founded” African Medicines Agency.

Africa flags on the map
Pan-African drug assessments are being trialed in a pilot scheme • Source: Shutterstock

The European Medicines Agency has awarded a grant to a pilot program that is trialing procedures for the joint assessment of drug approval applications at continental level in Africa.

The one-year pilot, which is being led by the African Union Development Agency New Partnership for Africa’s Development (AUDA-NEPAD) under the African Medicines Regulatory Harmonisation (AMRH) initiative, is part of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

International Group Aims To Shape The Inevitable Future Of AI In Pharmacovigilance

 
• By Urtė Fultinavičiūtė

Pharmacovigilance is a perfect rule-based and manual work-intensive playground for experimenting with AI. While some off-patent drug firms are already exploring new automation tools, regulation is lagging behind, leaving a gap for uncertainty.

UK Health Data Research Service Looks ‘Encouraging’ For Industry, But Implementation Details Will Be Key

 
• By Anabel Costa-Ferreira

Marcus Vass and Vladimir Murovec of international law firm Osborne Clarke tell the Pink Sheet what the government's planned HDRS might mean for industry, and how it compares with the European Health Data Space.

EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

 
• By Eliza Slawther

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.

EU Wants Industry To Define ‘Trade Secrets’ Under Health Data Sharing Regulation

 
• By Eliza Slawther

The European Health Data Space Regulation is deliberately “vague” when it comes to defining trade secrets because the EU wants the pharma industry to make recommendations on safeguarding intellectual property, a policy officer for the European Commission says.

More from Middle East & Africa

Japan Ships First Batch Of Mpox Vaccines To DRC

 
• By Lisa Takagi

Japan ships the first batch of 50,000 mpox vaccine doses to DRC after training local healthcare providers dealing with the persistent outbreak.

African Regulators Reach Big WHO Milestones

 
• By Francesca Bruce

Egypt is the first African country to win a WHO maturity level 3 benchmarking rating for medicines and vaccines that are locally produced and imported.

EU HTA Regulation: Views Wanted On Draft Rules On Joint Scientific Consultations

 
• By Francesca Bruce

A newly published draft implementing act sets out the procedural rules for the joint scientific consultations that are foreseen by the EU’s Health Technology Assessment Regulation.